Sandu Pharmaceuticals

Sandu Pharmaceuticals Net Margin

The Net Profit Margin of Sandu Pharmaceuticals (524703.BO) as of Oct 31, 2026 is 2.53 %. In the previous year, Net Profit Margin was 2.31 % — a change of 9.56% (higher).

Net Margin

2.53 %

YoY

9.56%

Last updated:

Net Profit Margin of Sandu Pharmaceuticals is 2026 2.53 % . Net Profit Margin of Sandu Pharmaceuticals was 2025 2.31 % . It decreases by 9.56% higher compared to the previous year.

For Sandu Pharmaceuticals, the net margin of 2.5% is broadly stable versus 2.4% a few years ago.

The Sandu Pharmaceuticals Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
1.35 INR
Jan 1, 2020
1.49 INR
Jan 1, 2021
1.86 INR
Jan 1, 2022
2.43 INR
Jan 1, 2023
2.33 INR
Jan 1, 2024
2.17 INR
Jan 1, 2025
2.31 INR
Jan 1, 2026
2.53 INR
The Sandu Pharmaceuticals Net Margin history
YEARNet MarginYoY
2.53 %+9.56%
2.31 %+6.15%
2.17 %-6.67%
2.33 %-4.12%
2.43 %+30.51%
1.86 %+24.85%
1.49 %+10.01%
1.35 %+18.52%
1.14 %+20.80%
0.95 %-27.83%
1.31 %+24.86%
1.05 %-23.98%
1.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sandu Pharmaceuticals Stock analysis

What does Sandu Pharmaceuticals do? Sandu Pharmaceuticals Ltd is a Mumbai-based company operating in the Consumer Staples sector, specifically within the consumer products industry. Listed on September 26, 1994, the firm manufactures and markets Ayurvedic medicines. Its product portfolio spans digestive health, immunity, muscle and bone health, respiratory health, and general wellness. Specific offerings address conditions such as constipation, hyperacidity, asthma, and colds, while also covering female, male, and mother-and-child wellness. The company utilizes in-house know-how from Sandu Brothers Private Limited for production and distributes its goods, including immunity kits and power herbs, through e-commerce marketplaces. Sandu Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sandu Pharmaceuticals stock

Net Profit Margin of Sandu Pharmaceuticals is 2.53 % in 2026.

Net Profit Margin of Sandu Pharmaceuticals changed from 2.31 % to 2.53 %, representing a 9.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Sandu Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Sandu Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Sandu Pharmaceuticals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Sandu Pharmaceuticals